← Eichor
Condition: Distributive Shock Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Distributive Shock

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Efficacy and Safety of Angiotensin II Injection Versus Placebo in Patients With Refractory Distributed Shock
Phase 3 · 42 location(s) · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · NCT06351150Hemodynamic Effects of Norepinephrine Reduction on Critical Closing Pressure in Distributive Shock
Phase N/A · 1 location(s) · Peking Union Medical College Hospital · NCT07653659Angiotensin II Stress Test. Renin Kinetics During Treatment of Vasoplegic Shock With Angiotensin II.
Phase N/A · 2 location(s) · University Medical Centre Maribor · NCT06539234
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.